Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Zika virus: an unlikely new anti-cancer candidate

Scientists at Cambridge University, funded by Cancer Research UK, are investigating the potential for Zika virus to be weaponised against brain tumour cells. The researchers have received funding to test the effect of Zika on glioblastoma, one of the most common and aggressive forms of brain tumour. With a five-year survival rate of just 5% for glioblastoma patients, could this unlikely source yield a powerful new treatment option for patients, and are there any risks involved?

Go Top